Patent details

EP2844233 Title: ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES

Basic Information

Publication number:
EP2844233
PCT Application Number:
US2013039018
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137850095
PCT Publication Number:
WO2013166117
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES
French Title of Invention:
FORMULATION DE COMPRIMÉ ORAL CONSTITUÉE D'UNE COMBINAISON FIXE DE ROSUVASTATINE ET D'ÉZÉTIMIBE POUR LE TRAITEMENT DE L'HYPERLIPIDÉMIE ET DE MALADIES CARDIOVASCULAIRES
German Title of Invention:
ORALE TABLETTENFORMULIERUNG AUS EINER FIXIERTEN KOMBINATION AUS ROSUVASTATIN UND EZETIMIB ZUR BEHANDLUNG VON HYPERLIPIDÄMIE UND HERZ-KREISLAUF-ERKRANKUNGEN
SPC Number:

Dates

Filing date:
01/05/2013
Grant date:
06/05/2020
EP Publication Date:
11/03/2015
PCT Publication Date:
07/11/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/05/2020
EP B1 Publication Date:
06/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/05/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/04/2020
 
 

Name:
Althera Life Sciences, LLC
Address:
1448 89 Headquarters Plaza, Morristown, NJ 07960, United States (US)

Inventor

Name:
DIAS, Marie, Charmaine
Address:
United States (US)

Priority

Priority Number:
201261641013 P
Priority Date:
01/05/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/24; A61K 31/397; A61K 31/505;

Publication

European Patent Bulletin

Issue number:
202019
Publication date:
06/05/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
UAB NIUM EU + patentrenewal com ApS
Filing date Document type Number of pages